arrow_back Trending Legislation
Share share

Supporting July 2023 as National Sarcoma Awareness Month.

The US Senate officially supported designating July 2023 as National Sarcoma Awareness Month. This resolution aims to highlight sarcoma, a rare cancer often misdiagnosed, affecting bones and connective tissues. The goal is to encourage better public recognition of symptoms, leading to earlier diagnosis and improved treatment outcomes for the thousands affected annually.
Key points
Increased public awareness regarding sarcoma, a rare cancer affecting approximately 16,000 individuals in the US each year.
Encouragement for citizens to seek proper diagnosis and treatment, addressing the issue of sarcoma being frequently misdiagnosed.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Adopted
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A resolution expressing support for the designation of July 2023 as "National Sarcoma Awareness Month".
Print number: SRES 249
Sponsor: Sen. Johnson, Ron [R-WI]
Process start date: 2023-06-13
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Supporting July 2023 as National Sarcoma Awareness Month.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is SRES 249.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-06-13.

What are the main provisions?

Key points include:

  • Increased public awareness regarding sarcoma, a rare cancer affecting approximately 16,000 individuals in the US each year.
  • Encouragement for citizens to seek proper diagnosis and treatment, addressing the issue of sarcoma being frequently misdiagnosed.

What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Johnson, Ron [R-WI].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2071; text: CR S2075)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of SRES 249

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health